东富龙 (300171)
Tofflon Science and Technology Group Co.,Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 76582.80
- Circulating A-Shares(W): 56265.74
- Earnings Per Share(RMB): 0.1729
- Net Assets Per Share(RMB): 10.2527
- Operating Revenue(W RMB): 370382.16
- Total Profit(W RMB): 16836.68
- Net Profit Attributable to Parent(W RMB): 13157.68
- Net Profit Growth Rate(%): -13.86
- Weighted Return on Equity(%): 1.68
- Operating Cash Flow Per Share(RMB): 0.4230
- Undistributed Profit Per Share(RMB): 4.0557
- Capital Reserve Per Share(RMB): 4.6025
2. Main Business
The main business covers:
- Bioprocess Segment
- Formulation Segment
- Engineering Integrated Solutions Segment
- Food Equipment Engineering Segment
3. Company Basic Information
- Company Name: Tofflon Science and Technlolgy Group Co., Ltd.
- Listing Date: 2011-02-01
- Industry: Special Purpose Equipment Manufacturing
- Address: No.1509, Duhui Road, Minhang District, Shanghai, China
- Website: www.tofflon.com
- Company Profile: The Company was established as a joint stock limited company through the overall transformation of Shanghai Tofflon Technology Co., Ltd. in accordance with the "Company Law". The promoters of the Company are Mr. Zheng Xiaodong, Mr. Zheng Xiaoyou, and Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. On April 9, 2008, the Company obtained the "Business License of Enterprise Legal Person" after the transformation into a joint stock company (Registration No.: 310112000078806). The approved and registered enterprise name is Shanghai Tofflon Technology Co., Ltd.; the domicile is No. 2199 Fanghe Road, Minhang District, Shanghai; the enterprise type is a joint stock limited company; and the registered capital is 60 million yuan.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | SDIC Capital Investment Management Co., Ltd. - Advanced Manufacturing Industry Investment Fund Phase II (Limited Partnership) | Asset Management Plan | 2430.72 | 4.32 |
| 2 | Shanghai Biomedical Industry Equity Investment Fund Partnership (Limited Partnership) | General Legal Person | 2430.72 | 4.32 |
| 3 | Shanghai Junhe Licheng Investment Management Center (Limited Partnership) - Ningbo Junhe Tongxin Equity Investment Partnership (Limited Partnership) | General Legal Person | 1458.43 | 2.59 |
| 4 | Yuekai Capital Investment Co., Ltd. - Guangzhou Yuekai Medical & Health Equity Investment Partnership (Limited Partnership) | General Legal Person | 972.29 | 1.73 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 822.18 | 1.46 |
| 6 | Nord Fund - Shanghai Guoxin Investment Development Co., Ltd. - Nord Fund Pujiang 890 Single Asset Management Plan | Asset Management Plan | 481.28 | 0.86 |
| 7 | Southern China Securities 1000 Exchange Traded Open-End Index Securities Investment Fund | Fund | 350.16 | 0.62 |
| 8 | Shanghai Gaoyi Asset Management Partnership (Limited Partnership) - Gaoyi Linshan No.1 Yuanwang Fund | General Legal Person | 300.00 | 0.53 |
| 9 | Jinxin Shenzhen Growth Flexible Allocation Hybrid Fund A Class | Fund | 234.08 | 0.42 |
5. Concept Sectors
- Biological Vaccine
- Intelligent Machine
- Gene Concept
- Immunotherapy
- Synthetic Biology
- DeepSeek
- Margin Trading & Securities Lending
- ChiNext 300
- ChiNext 200
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information